|
Volumn 15, Issue 5, 2013, Pages 401-408
|
The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOANTIBODY;
C PEPTIDE;
GLUCOSE;
INSULIN;
STEROID;
ADOLESCENT;
ADULT;
ANAPHYLAXIS;
ARTICLE;
CHILD;
CLINICAL ARTICLE;
CLINICAL EFFECTIVENESS;
CONTROLLED STUDY;
DIABETIC KETOACIDOSIS;
DRUG DOSE INCREASE;
FEMALE;
GLYCEMIC CONTROL;
HOME CARE;
HOSPITAL PATIENT;
HUMAN;
HYBRID CLOSED LOOP CONTROL;
HYPOGLYCEMIA;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN PUMP;
INSULIN TREATMENT;
INTENSIVE CARE;
MALE;
MULTICENTER STUDY;
OUTPATIENT CARE;
PANCREAS ISLET BETA CELL;
PANCREAS ISLET CELL FUNCTION;
PRESERVATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCHOOL CHILD;
SENSOR AUGMENTED PUMP THERAPY;
ADMINISTRATION, INTRAVENOUS;
ADOLESCENT;
ADULT;
ALGORITHMS;
BLOOD GLUCOSE;
CHILD;
DIABETES MELLITUS, TYPE 1;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INPATIENTS;
INSULIN;
INSULIN INFUSION SYSTEMS;
MALE;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 84877639101
PISSN: 15209156
EISSN: 15578593
Source Type: Journal
DOI: 10.1089/dia.2013.0002 Document Type: Article |
Times cited : (18)
|
References (4)
|